Draft genome sequence of isolate staphylococcus aureus LHSKBclinical, isolated from an infected hip by Stipetic, Laurence H. et al.
Enlighten – Research publications by members of the University of Glasgow 
http://eprints.gla.ac.uk 
 
 
 
 
Stipetic, L. H., Hamilton, G., Dalby, M. J., Davies, R. L., Meek, R.M. 
D., Ramage, G., Smith, D. G.E., and Burgess, K. E.V. (2015) Draft 
genome sequence of isolate staphylococcus aureus LHSKBclinical, 
isolated from an infected hip. Genome Announcements, 3(2), e00336-15. 
 
 
 
Copyright © 2015 The Authors 
 
This work is made available under the Creative Commons Attribution 3.0 
License (CC BY 3.0)      
 
 
 
 
Version: Published 
 
 
http://eprints.gla.ac.uk/104531/  
 
 
 
 
 
Deposited on: 25 May 2015 
 
 
Draft Genome Sequence of Isolate Staphylococcus aureus
LHSKBClinical, Isolated from an Infected Hip
Laurence H. Stipetic,a,b Graham Hamilton,b Matthew J. Dalby,c Robert L. Davies,a R. M. Dominic Meek,e Gordon Ramage,a,d
David G. E. Smith,a,f Karl E. V. Burgessa,b
Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdoma; Glasgow Polyomics,
University of Glasgow, Glasgow, United Kingdomb; Institute of Molecular Cell and Systems Biology, University of Glasgow, Glasgow, United Kingdomc; GlasgowDental School,
School of Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdomd; Department of Orthopedics, Southern General Hospital,
Glasgow, United Kingdome; Moredun Research Institute, Edinburgh, United Kingdomf
We report here the genome sequence of a clinical isolate of Staphylococcus aureus from an orthopedic infection. Phenotypically
diverse Staphylococcus aureus strains are associated with orthopedic infections and subsequent implant failure, and some are
highly resistant to antibiotics. This genome sequence will support further analyses of strains causing orthopedic infections.
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Members of the genus Staphylococcus are primarily responsi-ble for orthopedic infections after arthroplasty surgery
(1–3) and subsequent implant failure (4). When isolated from
orthopedic cases (2), Staphylococcus aureus is considered a pri-
mary medical concern due to the emergence of antimicrobial-
resistant strains (5) and the ability of S. aureus to attach to surfaces
and excrete an extracellular matrix to form biofilms (1, 6). Biofilm
formation has been shown to exacerbate antibiotic resistance (7,
8), providing a protective environment for the indwelling bacte-
ria. Biofilm cells display an altered gene expression profile (9) and
metabolism in contrast to their planktonic counterparts (10–12).
Differences occur in biofilm capability between S. aureus strains,
with certain strains forming biofilms more readily than others (6).
A number of genes have been found to be important in the for-
mation of a biofilm by S. aureus (9).
S. aureus LHSKBClinical was isolated at the Southern General
Hospital Microbiology laboratories (Glasgow, United Kingdom)
from pus aspirated from the hip of a 75-year-old female. Specia-
tion was confirmed on the basis of a positive Staph Xtra latex test
(Pro-Lab Diagnostics) and growth on bioMérieux chromID agar
(SAID). Genomic DNA was prepared from a brain-heart infusion
(BHI) broth culture using the DNeasy blood and tissue kit
(Qiagen) according to the manufacturer’s instructions, utilizing
the protocol for Gram-positive cell lysis (13). Sequencing was car-
ried out using the Illumina MiSeq system, employing 300-bp
paired-end sequencing. The reads were trimmed of Illumina
adapter sequences and low-quality bases, and then de novo assem-
bled and scaffolded using the CLC Genomics Workbench version
7.5.1 (Qiagen). Assembled scaffolds totaled 24, consisting of a
total of 2,762,774 bp with anN50 of 587,246 bp and an A-T content
of 67%, similar to other sequenced strains of S. aureus (14, 15).
Assembled scaffolds were annotated using the Rapid Annotations
using Subsystem Technology (RAST) resource (16, 17). The ge-
nome sequence was predicted to encode 2,566 proteins.
Interrogating http://saureus.mlst.net (18–20) showed that this
strain did not match any existing sequence type, and alignment of
assembled scaffolds using NCBI BLAST searches (21) and Mauve
genome analysis software (22) identified regions of heterogeneity
compared against other previously sequenced S. aureus genomes.
Genes encoding icaA and icaD, polysaccharide intracellular ad-
hesion proteins associated with S. aureus biofilm formation (9),
were found. Furthermore, sarA, another gene implicated in bio-
film formation by S. aureus (23, 24), was also found in the genome.
Moreover, fnbB was found in the genome, perceived as a possible
genetic marker for biofilm formation (25). Additionally, several
genes encoding exotoxins or superantigens were found in the ge-
nome, including several associated with super-antigen-encoding
S. aureus pathogenicity islands (SaPI), a virulence factor respon-
sible for increased pathogenicity (26, 27).
The genome shows a novel sequence type for this isolate and
provides a reference genome for S. aureus from orthopedic infec-
tions, both aspects of pertinence to further comparative studies of
S. aureus pathogenicity.
Nucleotide sequence accessionnumbers.This whole-genome
shotgun project has been deposited at DDBJ/EMBL/GenBank un-
der the accession number JZAL00000000. The version described
in this paper is version JZAL01000000.
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